IXEMPRA[TM], is an epothilone approved as monotherapy for the treatment of patients with metastatic or locally advanced breast cancer
in patients whose tumors are resistant or refractory to anthracyclines, taxanes, and capecitabine.
Phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin bound paclitaxel (nab-paclitaxel) and carboplatin in HER2+ locally advanced breast cancer
(Abstract 627, Poster 19E)
com/reports/c16790 ) has announced the addition of Breast Cancer - Changing Treatment Paradigms For Local And Locally Advanced Breast Cancer
to their offering.
Duke University has previously reported promising results from a Phase I breast cancer study designed to demonstrate the ability of thermotherapy to enhance the therapeutic activity of non temperature sensitive liposomal encapsulations of doxorubicin plus traditional paclitaxel (Taxol(R)) in the management of locally advanced breast cancer
reported data from its Phase 2 trial evaluating ADVEXIN(R) combined with neoadjuvant chemotherapy in women with locally advanced breast cancer
com/reports/c19291) has announced the addition of Breast Cancer - Changing Treatment Paradigms For Local And Locally Advanced Breast Cancer
to their offering.
Celsion has obtained exclusive rights to an advanced phased array radio frequency (RF) heating system designed specifically for use with chemotherapeutic drugs for the treatment of locally advanced breast cancer
Femara, an oral once-a-day therapy, is currently licensed in the UK for the first-line treatment of hormone receptor positive or hormone receptor unknown locally advanced breast cancer
in postmenopausal women and is proven to be superior to tamoxifen as first-line therapy in advanced disease.
Food and Drug Administration (FDA) approved its breast cancer treatment Arimidex(R) (anastrozole) as a new treatment option for postmenopausal women first diagnosed with advanced or locally advanced breast cancer
whose cancers are hormone receptive.
Genomic Health and the Istituto Nazionale Tumori performed RNA analysis of 383 genes in stored, paraffin-embedded tumor biopsies from 89 patients with locally advanced breast cancer
treated with doxorubicin and paclitaxel to determine whether these genes were predictive in cases in which chemotherapy caused the cancer to disappear, known as a pathologic complete response.